Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Long-Term Debt Repayments (2017)

Historic Long-Term Debt Repayments for Viking Therapeutics (VKTX) over the last 1 years, with Q3 2017 value amounting to -$223000.0.

  • Viking Therapeutics' Long-Term Debt Repayments changed N/A to -$223000.0 in Q3 2017 from the same period last year, while for Dec 2018 it was -$223000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $3.8 million for FY2018, which is 487792.21% up from last year.
  • According to the latest figures from Q3 2017, Viking Therapeutics' Long-Term Debt Repayments is -$223000.0.
  • Over the past 5 years, Viking Therapeutics' Long-Term Debt Repayments peaked at -$223000.0 during Q3 2017, and registered a low of -$223000.0 during Q3 2017.